- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05882448
Etude de l'influence de l'insufflation intrapéritonéale de CO2 par laparoscopie sur l'évolution à court terme des prématurés atteints d'entérocolite nécrosante ulcéreuse (NECO2)
Étude de l'influence de l'insufflation intrapéritonéale de dioxyde de carbone (CO2) par laparoscopie sur l'évolution à court terme des prématurés atteints d'entérocolite nécrosante ulcéreuse
Ulcerative-necrotizing enterocolitis (ECUN) is an infectious and inflammatory disease of the digestive tract, which can lead to intestinal necrosis or perforation.
This severe pathology of the newborn , often premature, requires urgent medical and surgical treatment in 25 to 50% of cases. The morbidity is high, both digestive and neurological. ECUN can lead to complications at short-term (death, intestinal stenosis) and at long-term (neuro-cognitive disorders). The challenge of preserving the neurological development is a major issue. It involves control of inflammation. This inflammation causes neurological lesions and is responsible for a disorder of the long-term neurocognitive development.
At Robert-Debré and Trousseau, the management of newborns with ECUN is focused on the control of this inflammation. A laparoscopy is performed first. The carbon dioxide (CO2) insufflated into the abdomen during a laparoscopy is thought to have an anti-inflammatory effect according to several experimental and clinical studies. A preliminary retrospective study at Robert-Debré showed a decrease in postoperative inflammation (decrease in C reactive protein at Day2 and Day 7 post-op) as well as a decrease in morbimortality (decrease in the rate of stoma and reoperation) in children who had a laparoscopic first operation compared to those who had a laparotomy alone. However, in many hospitals, laparotomy alone is currently the only surgical option.
This preliminary study may demonstrate that laparoscopy decreases early morbidity and mortality in children with ECUN through reduced inflammation, as reflected by postoperative C reactive protein.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
NECO2 is a pilot trial, evaluating the intermediate effectiveness to short/medium term of laparoscopy on the inflammatory reaction of premature newborns with complicated ECUN, requiring surgical treatment.
This is a multicenter randomized controlled trial in single blind, in two parallel arms, in ratio 1:1, of superiority.
This trial compares laparoscopy plus laparotomy versus laparotomy alone.
Children will be randomized into 2 groups:
- Laparoscopy + laparotomy group
- Laparotomy group
The main objective is to evaluate the inflammatory response Day 2 postoperative in preterm infants with ECUN who have undergone surgery.
The main criterion is the evolution of the blood C reactive protein level between Day 0 and Day 2 postoperatively.
The secondary objectives are:To evaluate in premature babies with ECUN who have had a surgical intervention (laparoscopy + laparotomy or laparotomy alone):
A.The postoperative biological inflammatory response at Day 7 B.Post-operative biological inflammatory response from Day 0 to Day 7 C.Post-operative mortality D.Post-operative bowel morbidity E.Post-operative re-intervention rate F.Length of hospital stay G.Post-operative neurological morbidity, medium term (corrected term 41 SA)
- To evaluate the tolerance of laparoscopy :
H.Intraoperative cardiorespiratory I.Loco-regional lesions linked to the insertion of the trocar
Secondary endpoints:
A. C reactive protein blood level at Day 7 B. Blood levels of Procalcitonin, Interleukin 6 and Tumor Necrosis Factor-alpha at Day 1, Day 2, Day 4, Day 7 C. Postoperative death from any cause D. Stoma rate, duration of parenteral nutrition, duration of hemodynamic support, duration of invasive ventilation (High frequency oscillatory ventilation/Synchronized Intermittent Mandatory Ventilation), Post-ECUN intestinal stenosis rate E. Re-intervention (laparotomy) and cause (post-ECUN stenosis, stoma closure) F. Length of hospital stay until return home G. Early postoperative neurological lesions observed on transfontanellar ultrasound and MRI at the corrected term of 41 weeks of amenorrhea, H. Oxygen saturation (SaO2), hypercapnia (pCO2) blood pressure (BP), cerebral oxygenation (Near InfraRed Spectroscopy (NIRS)) intraoperatively I. Intraoperative clinical monitoring: exploration of adjacent organs. Post-operative clinical monitoring: digestive signs monitoring of wounds until discharge.
Group 1: laparotomy only Group 2: laparotomy and laparoscopy
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Louise MONTALVA, Dr
- Numéro de téléphone: +33 1.71.73.89.97
- E-mail: louise.montalva@aphp.fr
Sauvegarde des contacts de l'étude
- Nom: Arnaud BONNARD, Pr
- Numéro de téléphone: +33 1 40 03 23 59
- E-mail: arnaud.bonnard@aphp.fr
Lieux d'étude
-
-
-
Paris, France, 75012
- Recrutement
- Hôpital Armand Trousseau Service de Chirurgie Pédiatrique et Néonatale
-
Contact:
- MONTALVA Louise, Dr
- Numéro de téléphone: +33 +33 1.71.73.89.97
- E-mail: louise.montalva@aphp.fr
-
Paris, France
- Recrutement
- Hôpital Robert Debré Service de Chirurgie Pédiatrique
-
Contact:
- BONNARD Arnaud, Pr
- Numéro de téléphone: +33 33 1 40 03 41 21
- E-mail: arnaud.bonnard@aphp.fr
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Premature newborn (term of birth: <37 weeks of amenorrhea)
- Diagnosis of ECUN by the surgeon (distension abdominal +/- rectal bleeding +/- green gastric residue, increased biological inflammatory syndrome, + pneumatosis on abdominal radiography)
- Hospitalized and complicated ECUN: presenting either a pneumoperitoneum on abdominal X-ray or a absence of clinical and biological improvement after 48 hours of maximum well-conducted medical treatment (IV antibiotic therapy and digestive rest).
- Hospitalized in the 2 participating centers
- Of which the 2 holders of parental authority have been informed and have signed the consent form
- Having social security coverage (social security or CMU)
Exclusion Criteria:
- Instability contraindicating movement to the operating room or contraindicating CO2 insufflation
- Diagnosis of isolated perforation of the small intestine (radiography:
pneumoperitoneum without pneumatosis)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Laparotomy
Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion |
Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion |
|
Expérimental: Laparotomy and laparoscopy
Exploratory and therapeutic laparotomy if necessary preceded by laparoscopy with insufflation of CO2 (placement of a 3mm trocar in the left hypochondrium and insufflation of a pneumoperitoneum (carbon dioxide, pressure: 6 mmHg, flow rate: 1.5 Liter/minute) for a duration of at least 5 minutes. |
Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion laparoscopy with insufflation of CO2 (placement of a 3mm trocar in the left hypochondrium and insufflation of a pneumoperitoneum (carbon dioxide, pressure: 6 mmHg, flow rate: 1.5 Liter/minute) for a duration of at least 5 minutes. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
C reactive protein blood level
Délai: between Day 0 and Day 2 post surgery
|
C reactive protein blood level |
between Day 0 and Day 2 post surgery
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Postoperative biological inflammatory reaction
Délai: Day 7 post surgery
|
C reactive protein blood level |
Day 7 post surgery
|
|
Specific post-operative biological inflammatory reaction
Délai: Day1, day 2, day 4 and day 7 post surgery
|
Procalcitonin, Interleukin 6 and Tumor Necrosis Factor-alpha blood level |
Day1, day 2, day 4 and day 7 post surgery
|
|
Postoperative mortality
Délai: up to 3 months
|
Death due to any postoperative cause |
up to 3 months
|
|
Postoperative intestinal morbidity: stoma rate
Délai: up to 3 months
|
Stoma rate |
up to 3 months
|
|
Postoperative intestinal morbidity: Duration of parenteral nutrition
Délai: up to 3 months
|
Duration of parenteral nutrition |
up to 3 months
|
|
Postoperative intestinal morbidity: Duration of hemodynamic support
Délai: up to 3 months
|
Duration of hemodynamic support |
up to 3 months
|
|
Postoperative intestinal morbidity: Duration of invasive ventilation (HFO: High frequency oscillatory ventilation/VACI: Synchronized Intermittent Mandatory Ventilation)
Délai: up to 3 months
|
Duration of invasive ventilation (HFO: High frequency oscillatory ventilation/VACI: Synchronized Intermittent Mandatory Ventilation) |
up to 3 months
|
|
Postoperative intestinal morbidity: Rate of intestinal stenosis post-ECUN
Délai: up to 3 months
|
Rate of intestinal stenosis post-ECUN |
up to 3 months
|
|
Postoperative reoperation rate
Délai: up to 3 months
|
Reoperation (laparotomy) and cause (post ECUN stenosis, stoma closure) |
up to 3 months
|
|
Length of hospitalization
Délai: up to 3 months
|
Duration of hospitalization until return home |
up to 3 months
|
|
Medium-term postoperative neurological morbidity
Délai: up to 3 months
|
Early postoperative neurological lesions observed on transfontanellar ultrasound and MRI at term corrected for 41 weeks of amenorrhea |
up to 3 months
|
|
Oxygen saturation (SaO2) (Tolerance of laparoscopy (Intraoperative cardio-respiratory))
Délai: During Surgery
|
Oxygen saturation (SaO2) |
During Surgery
|
|
Hypercapnia (pCO2) (Tolerance of laparoscopy (Intraoperative cardio-respiratory))
Délai: During Surgery
|
hypercapnia (pCO2) |
During Surgery
|
|
Blood pressure (BP) (Tolerance of laparoscopy (Intraoperative cardio-respiratory))
Délai: During Surgery
|
blood pressure (systolic and diastolic) |
During Surgery
|
|
Cerebral oxygenation (Near InfraRed Spectroscopy (NIRS)) (Tolerance of laparoscopy (Intraoperative cardio-respiratory))
Délai: During Surgery
|
cerebral oxygenation (Near InfraRed Spectroscopy (NIRS)) intraoperatively |
During Surgery
|
|
Presence of loco-regional lesions related to the insertion of the trocar (Tolerance of laparoscopy)
Délai: up to 3 months
|
Presence of loco-regional lesions related to the insertion of the trocar |
up to 3 months
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies urogénitales
- Maladies urogénitales féminines et complications de la grossesse
- Maladies intestinales
- Travail obstétrique, prématuré
- Complications du travail obstétrical
- Complications de grossesse
- Maladies du système digestif
- Maladies gastro-intestinales
- Gastro-entérite
- Entérocolite
- Naissance prématurée
- Entérocolite nécrosante
- Techniques et procédures de diagnostic
- Diagnostic
- Procédures chirurgicales, opératoires
- Procédures chirurgicales mini-invasives
- Techniques de diagnostic, chirurgicale
- Endoscopie
- Laparoscopie
- Laparotomie
Autres numéros d'identification d'étude
- APHP221170
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .